Shecure Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -1576.08%
(FY 2023)
- Ebitda -5564.50%
(FY 2023)
- Net Worth -6.70%
(FY 2023)
- Total Assets 0.05%
(FY 2023)
About Shecure Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Kumar and Pushpa Thakur serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC199048
- Company No.
199048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shecure Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kumar  | Director | 12-Feb-2010 | Current |
| Pushpa Thakur | Director | 12-Feb-2010 | Current |
Financial Performance of Shecure Laboratories.
Shecure Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1576.08% decrease in profit. The company's net worth dipped by a decrease of 6.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shecure Laboratories?
In 2021, Shecure Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramose Laboratories Private LimitedActive 22 years 2 monthsAnil Kumar and Pushpa Thakur are mutual person
Hecure Agro Plants Private LimitedActive 8 years 6 monthsAnil Kumar and Pushpa Thakur are mutual person
- Hecure Health Care Private LimitedActive 20 years 10 months
Anil Kumar and Pushpa Thakur are mutual person
- Hecure Products Private LimitedActive 16 years 16 days
Anil Kumar and Pushpa Thakur are mutual person
- Hecure Developers Private LimitedActive 12 years 1 month
Anil Kumar and Pushpa Thakur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shecure Laboratories?
Unlock and access historical data on people associated with Shecure Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shecure Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shecure Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
